California State Teachers Retirement System Impel Pharmaceuticals Inc Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$5.83 - $10.12 $15,583 - $27,050
-2,673 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$5.86 - $9.85 $3,474 - $5,841
-593 Reduced 18.16%
2,673 $17,000
Q4 2021

Feb 15, 2022
BUY
$8.33 - $12.14 $3,398 - $4,953
408 Added 14.28%
3,266 $28,000
Q3 2021

Nov 15, 2021
SELL
$8.38 - $26.13 $38,598 - $120,354
-4,606 Reduced 61.71%
2,858 $35,000
Q2 2021

Aug 16, 2021
BUY
$7.33 - $15.2 $54,711 - $113,452
7,464 New
7,464 $66,000

Others Institutions Holding IMPL

# of Institutions
1
Shares Held
14.4K
Call Options Held
0
Put Options Held
0
View Full List

About IMPEL PHARMACEUTICALS INC

IMPL Quotes by TradingView
  • Ticker IMPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,738,800
  • Market Cap $475K
  • Description
  • Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...
More about IMPL
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email